RAPT Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPT and other ETFs, options, and stocks.About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
RAPT Key Statistics
Stock Snapshot
The current RAPT Therapeutics(RAPT) stock price is $33.38, with a market capitalization of 928.18M. The stock trades at a price-to-earnings (P/E) ratio of -3.02.
On 2025-12-31, RAPT Therapeutics(RAPT) stock traded between a low of $33.01 and a high of $35.95. Shares are currently priced at $33.38, which is +1.1% above the low and -7.1% below the high.
The RAPT Therapeutics(RAPT)'s current trading volume is 290.96K, compared to an average daily volume of 453.65K.
In the last year, RAPT Therapeutics(RAPT) shares hit a 52-week high of $42.39 and a 52-week low of $5.67.
In the last year, RAPT Therapeutics(RAPT) shares hit a 52-week high of $42.39 and a 52-week low of $5.67.
RAPT News
In December 2025, RAPT Therapeutics, Inc. was added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, following recent cli...
